Glaxo appoints new chief executive

One of the world’s largest pharmaceutical firms GlaxoSmithKline today announced a replacement for chief executive Jean-Paul Garnier.

Andrew Witty, 43, currently president for Glaxo’s European pharmaceuticals arm, will succeed Mr Garnier when he retires at the end of May.

Mr Witty joined Glaxo in 1985 and has held a number of senior roles within the group, including senior vice president Asia Pacific, based in Singapore.

Whilst in Singapore, he also acted as economic adviser to the Governor of Guangzhou, China.